Adcirca Oral Tablet 20Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Adcirca: Oral tablet (20mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file DrugItem_19114.JPG
Adcirca 20mg Tablet
United Therapeutics Corporation
Pill Identification: 4467 

What is this Medicine?

TADALAFIL (tah DA la fil) is used to treat pulmonary arterial hypertension. This is a serious heart and lung condition. This medicine helps to improve symptoms and quality of life.

In-Depth Information

Adcirca 20mg Tablet

NDC: 663020467
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Pulmonary Hypertension

Storage Information
Store at 77 degrees F; excursions permitted to 59-86 degrees F
Adcirca 20mg Tablet
Drug Image file DrugItem_19114.JPG
United Therapeutics Corporation
Pill Identification: 4467 
Shape: oval
Color: orange

Reported Side Effects for Adcirca 20mg Tablet

Dry Mouth Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Stomach Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Difficulty Swallowing Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Heart Attack Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Fainting Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Vomiting Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Weakness Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Swollen Eyelids Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Blurred Vision Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Chest Pain Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Conjunctivitis Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Elevated Hepatic Enzymes Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Heartburn Incidence:
<3.0%*
Severity: MILD
Onset: DELAYED
Deafness Incidence:
<2.0%*
Severity: SEVERE
Onset: DELAYED
Hypoesthesia Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Secretion Of Tears Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Paresthesias Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Skin Rash Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Rapid Heart Rate Incidence:
<2.0%*
Severity: MODERATE
Onset: RAPID
Upset Stomach Incidence:
<11.0%*
Severity: MILD
Onset: EARLY
Chest Pain Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Joint Pain Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Drowsiness Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Shortness Of Breath Incidence:
<2.0%*
Severity: MODERATE
Onset: EARLY
Swelling Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Nose Bleed Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Throat Inflammation Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Tired Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Inflamed Stomach Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Excessive Sweating Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Low Blood Pressure Incidence:
<2.0%*
Severity: MODERATE
Onset: RAPID
Inability To Sleep Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Balance Problems Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Ringing In Ears Incidence:
<2.0%*
Severity: MILD
Onset: DELAYED
Itching Incidence:
<2.0%*
Severity: MILD
Onset: RAPID
Postural Low Blood Pressure Incidence:
<2.0%*
Severity: MODERATE
Onset: DELAYED
Eye Pain Incidence:
<2.0%*
Severity: MILD
Onset: EARLY
Lightheadedness Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Flushing Incidence:
1.0-13.0%*
Severity: MILD
Onset: RAPID
Sore Throat Incidence:
1.0-13.0%*
Severity: MILD
Onset: DELAYED
High Blood Pressure Incidence:
1.0-3.0%*
Severity: MODERATE
Onset: EARLY
Upset Stomach Incidence:
1.0-13.0%*
Severity: MILD
Onset: EARLY
Muscle Pain Incidence:
1.0-14.0%*
Severity: MILD
Onset: EARLY
Loose Stools Incidence:
1.0-2.0%*
Severity: MILD
Onset: EARLY
Muscle And/Or Bone Pain Incidence:
1.4-3.0%*
Severity: MILD
Onset: EARLY
Stuffy Nose Incidence:
2.0-9.0%*
Severity: MILD
Onset: EARLY
Flu Incidence:
2.0-5.0%*
Severity: MILD
Onset: DELAYED
Infection Incidence:
2.0-13.0%*
Severity: MILD
Onset: DELAYED
Cough Incidence:
2.0-4.0%*
Severity: MILD
Onset: DELAYED
Back Pain Incidence:
2.0-12.0%*
Severity: MILD
Onset: DELAYED
Headache Incidence:
3.0-42.0%*
Severity: MILD
Onset: EARLY
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Daily Life Interactions for Adcirca 20mg Tablet

Elements of your daily lifestyle may have an effect on the medications you are taking. Drug interactions can result in unwanted side effects, reduce the effectiveness of your medicine or possibly increase the action of a particular medicine.

Moderate Lifestyle Interaction
Grapefruit juice and Adcirca 20mg Tablet(Tadalafil)
Grapefruit juice and Tadalafil(Tadalafil)
Grapefruit juice and grapefruit-containing foods may increase the side effects of Tadalafil (Cialis). Do not significantly alter grapefruit juice intake while taking this drug, or avoid grapefruit juice if possible. When taking Cialis, contact your prescriber immediately if you experience chest pain, dizziness, fainting or falling spells, palpitations, shortness of breath, or a change in your usual heart beat (fast, slow, or irregular heart beat).
Moderate Lifestyle Interaction
Alcohol and Adcirca 20mg Tablet(Tadalafil)
Alcohol and Tadalafil(Tadalafil)
Do not drink Alcohol to excess (examples, 5 glasses of wine or 5 shots of whiskey) when taking Tadalafil. When taken in excess, Alcohol can increase your chances of getting a headache or getting dizzy, increasing your heart rate or lowering your blood pressure.
Pregnancy & Lactation Information
FIRST Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

SECOND Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

THIRD Trimester

Class B - Animal studies have revealed no evidence of harm to the fetus, however, there are no adequate and well-controlled studies in pregnant women. OR Animal studies have shown an adverse effect, but adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in any trimester.

Lactation

Caution - Not enough information is available to rule out harm to infants when this drug is taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Adcirca

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5